Selective modulation of specific protein kinase C (PKC) isoforms in primary human megakaryocytic vs. erythroid cells

Anatomical Record

Volumn 255, Issue 1, 1999, Pages 7-14

  Marchisio, Marco ^a   Bertagnolo, Valeria ^a   Celeghini, Claudio ^a   Vitale, Marco ^b,c   Capitani, Silvano ^a   Zauli, Giorgio ^a,d  

^a UNIVERSITY OF FERRARA   (Italy)

^b Division of Human Anatomy   (Italy)

^c Inst Norm Pathol C   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

Author keywords

EPO; Hematopoietic differentiation; PKC; TPO

Indexed keywords

CD34 ANTIGEN; ERYTHROPOIETIN; PROTEIN KINASE C; THROMBOPOIETIN;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROID CELL; HEMATOPOIESIS; HUMAN; HUMAN CELL; MEGAKARYOCYTE; PHENOTYPE; PRIORITY JOURNAL;

CELL DIFFERENTIATION; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LEUKOCYTES, MONONUCLEAR; MEGAKARYOCYTES; PROTEIN ISOFORMS; PROTEIN KINASE C; THROMBOPOIETIN;

EID: 0032948361     PISSN: 0003276X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0185(19990501)255:1<7::AID-AR2>3.0.CO;2-T     Document Type: Article

References (24)

1. Alitalo R, Partanen J, Pertovaara L, Holtta E, Sistonen L, Anderson L, Alifalo K. 1990. Increased erythroid potentiating activity/tissue inhibitor of metalloproteinases and jun/fos transcription factor complex characterize tumor promoter-induced megakaryoblastic differentiation of K562 leukemia cells. Blood 75:1974-1982.
2. Barber DL, Corless CN, Xia K, Roberts TM, D'Andrea AD. 1997. Erythropoietin activates Raf1 by a She-independent pathway in CTLL-EPO-R cells. Blood 89:55-64.
3. Bertolaso L, Gibellini D, Secchiero P, Previati M, Falgione D, Capitani S, Zauli G. 1998. Accumulation of catalytically active PKC-ζ into the nucleus of the HL-60 myeloid cell line plays a key role in the induction of granulocytic differentiation mediated by all-trans retinoic acid. Br J Haematol 100:541-549.
4. Borgatti P, Zauli G, Cantley LC, Capitani S. 1998. HIV-1 Tat protein induces a rapid and selective activation of protein kinase C (PKC)-α, -∈, and -ζ isoforms in PC12 cells. Biochem Biophys Res Commun 242:332-337.
5. Dai W, Murphy MJ. 1993. Downregulation of GATA-1 expression during phorbol myristate acetate-induced megakaryocytic differentiation of human erythroleukemia cells. Blood 81:1214-1221.
6. Debili N, Coulombel L, Croisille L, Katz A, Guichard J, Breton-Gorius J, Vainchenker W. 1996. Characterization of a bipotent erythromegakaryocytic progenitor in human bone marrow. Blood 88:1284-1296.
7. Dekker LV, Parker PJ. 1994. Protein kinase C: a question of specificity. Trends Biochem Sci 19:73-77.
8. Fraser JK, Lin F-K, Berridge MV. 1988. Expression of high affinity receptors for erythropoietin on human bone marrow cells and on the human erythroleukemic cell line, HEL. Exp Hematol 16:836-842.
9. Hong Y, Martin JF, Vainchenker W, Erusalimsky JD. 1996. Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells. Blood 87:123-131.
10. Hug H, Sarre TF. 1993. Protein kinase C isoenzymes: divergence in signal tranduction? Biochem J 291:329-343.
11. Ishibashi T, Koziol JA, Burstein SA. 1987. Human recombinant erythropoietin promotes differentiation of murine megakaryocytes in vitro. J Clin Invest 79:286-289.
12. Long MW, Heffner CH, Williams JL, Peters C, Prochownik EV. 1990. Regulation of megakaryocyte phenotype in human erythroleukemia cells. J Clin Invest 85:1072-1080.
13. Mischak H, Pierce JH, Goodnight J, Kazanietz MG, Blumberg PM, Mushinski JF. 1993. Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-α and -δ and not by protein kinase C-βII, -∈, -ζ, and -η. J Biol Chem 268:20110-20115.
14. Miura Y, Miura O, Ihle JN, Aoki N. 1994. Activation of the mitogen-activated protein kinase pathway by erythropoietin receptor. J Biol Chem 267:29962-29969.
15. Namciu S, Lieberman MA, Stavnezer E. 1994. Induction of the c-ski proto-oncogene by phorbol ester correlates with induction of megakaryocyte differentiation. Oncogene 9:1407-1416.
16. Olson EN, Burgess R, Staudinger J. 1993. Protein kinase C as a tranducer of nuclear signals. Cell Growth Differ 4:699-705.
17. Orkin SH. 1995. Transcription factors and hematopoietic development. J Biol Chem 270:4955-4958.
18. Papayannopoulou TH, Raines E, Collins S, Nakamoto B, Tweedale M, Ross R. 1987. Constitutive and inducible secretion of platelet derived growth factor analogs by human leukemic cell lines coexpressing erythroid and megakaryocyte markers. J Clin Invest 79:859-866.
19. Romeo P, Prandini MH, Joulin V, Mignotte V, Prenant M, Vainchenker W, Marguerie G, Uzan G. 1990. Megakaryocytic and erythrocytic lineages share specific transcription factors. Nature 344:447-449.
20. Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, Jackson CW, Hunt P, Saris CJM, Orkin SH. 1995. Transcription factor NF-E2 is required for platelet formation independent of the action of thrombopoietin/MGDF in megakaryocyte development. Cell 81:695-704.
21. Strauss LC, Rowley SD, La Russa VF, Sharkis SS, Stuart RK, Civin CI. 1986. Antigen analysis of hematopoiesis. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp Hematol 14:878-885.
22. Zauli G, Catani L. 1995. Human megakaryocyte biology and pathophysiology. Crit Rev Oncol Hematol 21:135-157.
23. Zauli G, Bassini A, Catani L, Gibellini D, Celeghini C, Borgatti P, Caramelli E, Guidotti L, Capitani S. 1996. PMA-induced megakaryocytic differentiation of HEL cells is accompanied by striking modifications of protein kinase C catalytic activity and isoform composition at the nuclear level. Br J Haematol 92:530-536.
24. + cells. Blood 92:472-480.